This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2011 Oct 4;124(14):1508-10.

doi: 10.1161/CIRCULATIONAHA.111.054510.

Reversal of new oral anticoagulants

Elisabeth M Battinelli

PMID: 21969317
DOI: 10.1161/CIRCULATIONAHA.111.054510

Editorial

Reversal of new oral anticoagulants

Elisabeth M Battinelli. Circulation. 2011.

. 2011 Oct 4;124(14):1508-10.

doi: 10.1161/CIRCULATIONAHA.111.054510.

Author

Elisabeth M Battinelli

PMID: 21969317
DOI: 10.1161/CIRCULATIONAHA.111.054510

No abstract available

PubMed Disclaimer

Comment on

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects.
Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M. Eerenberg ES, et al. Circulation. 2011 Oct 4;124(14):1573-9. doi: 10.1161/CIRCULATIONAHA.111.029017. Epub 2011 Sep 6. Circulation. 2011. PMID: 21900088 Clinical Trial.

Similar articles

Letter by Marlu et al regarding article, "reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects".
Marlu R, Hodaj E, Pernod G. Marlu R, et al. Circulation. 2012 Apr 24;125(16):e615; author reply e616. doi: 10.1161/CIRCULATIONAHA.111.073122. Circulation. 2012. PMID: 22529073 No abstract available.
Letter by Bernstein et al regarding article, "reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects.
Bernstein RA, Alberts MJ, Garcia DA. Bernstein RA, et al. Circulation. 2012 Apr 24;125(16):e614; author reply e616. doi: 10.1161/CIRCULATIONAHA.111.073668. Circulation. 2012. PMID: 22529072 No abstract available.
Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects.
Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M. Eerenberg ES, et al. Circulation. 2011 Oct 4;124(14):1573-9. doi: 10.1161/CIRCULATIONAHA.111.029017. Epub 2011 Sep 6. Circulation. 2011. PMID: 21900088 Clinical Trial.
Emergency surgery and trauma in patients treated with the new oral anticoagulants: dabigatran, rivaroxaban, and apixaban.
Moorman ML, Nash JE, Stabi KL. Moorman ML, et al. J Trauma Acute Care Surg. 2014 Sep;77(3):486-94; quiz 486-94. doi: 10.1097/TA.0000000000000360. J Trauma Acute Care Surg. 2014. PMID: 25159255 Review. No abstract available.
Managing new oral anticoagulants in the intensive care unit.
Gass JA, Weeks PA. Gass JA, et al. Crit Care Nurs Q. 2013 Oct-Dec;36(4):390-9. doi: 10.1097/CNQ.0b013e3182a10f41. Crit Care Nurs Q. 2013. PMID: 24002428 Review.

See all similar articles

Cited by

Management of anticoagulation in hip fractures: A pragmatic approach.
Yassa R, Khalfaoui MY, Hujazi I, Sevenoaks H, Dunkow P. Yassa R, et al. EFORT Open Rev. 2017 Sep 21;2(9):394-402. doi: 10.1302/2058-5241.2.160083. eCollection 2017 Sep. EFORT Open Rev. 2017. PMID: 29071124 Free PMC article.
Use of hemodialysis for the treatment of intracerebral hemorrhage in patients on dabigatran with normal renal function.
Maw TT, Henry BL, Singh T. Maw TT, et al. Clin Nephrol Case Stud. 2014 Aug 20;2:18-22. doi: 10.5414/CNCS108253. eCollection 2014. Clin Nephrol Case Stud. 2014. PMID: 29043124 Free PMC article.
Widening the path and window of opportunity for FDA approval of non-vitamin K oral anticoagulant specific antidotes and reversal agents.
Patel S, Steen D. Patel S, et al. J Thromb Thrombolysis. 2016 Feb;41(2):285-92. doi: 10.1007/s11239-015-1272-9. J Thromb Thrombolysis. 2016. PMID: 26374107 Review.
Emergency reversal of anticoagulation: novel agents.
Levine M, Goldstein JN. Levine M, et al. Curr Neurol Neurosci Rep. 2014 Aug;14(8):471. doi: 10.1007/s11910-014-0471-7. Curr Neurol Neurosci Rep. 2014. PMID: 24969622 Review.
A new era of stroke prevention in atrial fibrillation: comparing a new generation of oral anticoagulants with warfarin.
Stambler BS. Stambler BS. Int Arch Med. 2013 Oct 31;6(1):46. doi: 10.1186/1755-7682-6-46. Int Arch Med. 2013. PMID: 24171796 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information